Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s11523-015-0360-2.

Title:
Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer | Targeted Oncology
Description:
Our preliminary studies identified a small population side population (SP) cells in pancreatic cancer cells with stem cell-like properties, which were able to induce fast and aggressive tumor formation in nude mice. Gene expression analysis showed a significant difference in the expression of more than 1,300 genes in SP cells, among which a highly significant difference in microRNA expression of miR-21 and miR-221 between SP and NSP cells was identified. SP cells were identified and characterized by flow cytometry using Hoechst 33342 dye staining from a highly metastatic human pancreatic cancer cell line (L3.6pl). Antagomir transfection was performed using miRNA-21 and miRNA-221 antisense oligonucleotides (ASOs) and followed by detection of cell apoptosis, cell cycle progression, chemosensitivity, and invasion. Sorted SP cells from gemcitabine-resistant L3.6pl cells (L3.6plGres-SP) cells were orthotopically implanted in nude mice with or without miRNA-21 and miRNA-221 ASOs mono- and combination therapy. The administration of antagomir-21 and antagomir-221 significantly reduced the SP cell fraction, decreased SP cell differentiation, and downstream gene regulation, and thereby induced reduction of L3.6pl cell proliferation, invasion, and chemoresistance against gemcitabine and 5-Fluorouracil. Combination of ASOs therapy against miRNA-21 and miRNA-221 significantly inhibited primary tumor growth and metastasis compared to single antagomir treatment, especially, in L3.6plGres-SP-induced pancreatic tumor growth in vivo. These findings further indicate that the inhibition of miR-21 and miR-221 appear particularly suitable to target stem-like subpopulations and address their specific biological function to promote tumor progression in pancreatic cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {๐Ÿ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {๐Ÿ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {๐Ÿ“ˆ}

What is the average monthly size of link.springer.com audience?

๐ŸŒ  Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {๐Ÿ’ธ}

We see no obvious way the site makes money.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {๐Ÿ”}

pubmed, cancer, article, cells, google, scholar, cas, pancreatic, cell, stem, population, microrna, central, zhao, human, side, tumor, wang, expression, research, munich, lplgressp, access, res, liu, tumors, resistance, bao, renner, bruns, celllike, metastatic, mirna, invasion, primary, targeting, rev, nat, oncol, privacy, cookies, content, stemlike, metastasis, jauch, peter, camaj, significant, antagomir, proliferation,

Topics {โœ’๏ธ}

month download article/chapter hypoxia-inducible factor-1alpha expression tgf-beta-mediated epithelial abc transporter bcrp1/abcg2 karl-walter jauch mir-21-mediated tumor growth cells modulates tumorigenesis proapoptotic genes mapk10/jnk3 otto-von-guericke university full article pdf related subjects microrna-200b reverses chemoresistance metastatic pancreatic cancer 6plgres-sp cells demonstrating human pancreatic adenocarcinoma advanced pancreatic carcinoma cancer stem cell pancreatic cancer cells cancer stem cells privacy choices/manage cookies human glioblastoma cells side-population phenotype highly significant difference human gastrointestinal system metastatic lesions generated primary tumors generated embryonic stem cells stepwise metastatic potentials fรถfole research program german research society tumor-initiating stem pancreatic cyst fluid posttranscriptional gene silencing side population cells cell population compared sp cell fraction side population purified side population derived cell cycle progression microrna expression signature transcriptional repression mediated multiple drug resistance underwent radical surgery mirna-221 antisense oligonucleotides aggressive tumor formation mirnas vivo tumor growth mir-222 expression affects sorted sp cells 6pl cell proliferation

Schema {๐Ÿ—บ๏ธ}

WebPage:
      mainEntity:
         headline:Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer
         description:Our preliminary studies identified a small population side population (SP) cells in pancreatic cancer cells with stem cell-like properties, which were able to induce fast and aggressive tumor formation in nude mice. Gene expression analysis showed a significant difference in the expression of more than 1,300 genes in SP cells, among which a highly significant difference in microRNA expression of miR-21 and miR-221 between SP and NSP cells was identified. SP cells were identified and characterized by flow cytometry using Hoechst 33342 dye staining from a highly metastatic human pancreatic cancer cell line (L3.6pl). Antagomir transfection was performed using miRNA-21 and miRNA-221 antisense oligonucleotides (ASOs) and followed by detection of cell apoptosis, cell cycle progression, chemosensitivity, and invasion. Sorted SP cells from gemcitabine-resistant L3.6pl cells (L3.6plGres-SP) cells were orthotopically implanted in nude mice with or without miRNA-21 and miRNA-221 ASOs mono- and combination therapy. The administration of antagomir-21 and antagomir-221 significantly reduced the SP cell fraction, decreased SP cell differentiation, and downstream gene regulation, and thereby induced reduction of L3.6pl cell proliferation, invasion, and chemoresistance against gemcitabine and 5-Fluorouracil. Combination of ASOs therapy against miRNA-21 and miRNA-221 significantly inhibited primary tumor growth and metastasis compared to single antagomir treatment, especially, in L3.6plGres-SP-induced pancreatic tumor growth in vivo. These findings further indicate that the inhibition of miR-21 and miR-221 appear particularly suitable to target stem-like subpopulations and address their specific biological function to promote tumor progression in pancreatic cancer.
         datePublished:2015-02-03T00:00:00Z
         dateModified:2015-02-03T00:00:00Z
         pageStart:535
         pageEnd:548
         sameAs:https://doi.org/10.1007/s11523-015-0360-2
         keywords:
            miRNAs
            Side population
            Tumorigenesis
            Metastasis
            Chemotherapy resistance
            Pancreatic cancer
            Oncology
            Biomedicine
            general
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig3a_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig3b_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig6_HTML.gif
         isPartOf:
            name:Targeted Oncology
            issn:
               1776-260X
               1776-2596
            volumeNumber:10
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yue Zhao
               affiliation:
                     name:Otto-von-Guericke University
                     address:
                        name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Lu Zhao
               affiliation:
                     name:University of Munich
                     address:
                        name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ivan Ischenko
               affiliation:
                     name:University of Munich
                     address:
                        name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qi Bao
               affiliation:
                     name:University of Munich
                     address:
                        name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bettina Schwarz
               affiliation:
                     name:University of Munich
                     address:
                        name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hanno NieรŸ
               affiliation:
                     name:University of Munich
                     address:
                        name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yan Wang
               affiliation:
                     name:Otto-von-Guericke University
                     address:
                        name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Andrea Renner
               affiliation:
                     name:University of Munich
                     address:
                        name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Josef Mysliwietz
               affiliation:
                     name:Institute of Molecular Immunology, Helmholtz Center Munich
                     address:
                        name:Institute of Molecular Immunology, Helmholtz Center Munich, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Karl-Walter Jauch
               affiliation:
                     name:University of Munich
                     address:
                        name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter J. Nelson
               affiliation:
                     name:University of Munich
                     address:
                        name:Clinical Biochemistry Group, Medizinische Klinik und Poliklinik IV, University of Munich, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joachim W. Ellwart
               affiliation:
                     name:Institute of Molecular Immunology, Helmholtz Center Munich
                     address:
                        name:Institute of Molecular Immunology, Helmholtz Center Munich, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christiane J. Bruns
               affiliation:
                     name:Otto-von-Guericke University
                     address:
                        name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter Camaj
               affiliation:
                     name:Otto-von-Guericke University
                     address:
                        name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer
      description:Our preliminary studies identified a small population side population (SP) cells in pancreatic cancer cells with stem cell-like properties, which were able to induce fast and aggressive tumor formation in nude mice. Gene expression analysis showed a significant difference in the expression of more than 1,300 genes in SP cells, among which a highly significant difference in microRNA expression of miR-21 and miR-221 between SP and NSP cells was identified. SP cells were identified and characterized by flow cytometry using Hoechst 33342 dye staining from a highly metastatic human pancreatic cancer cell line (L3.6pl). Antagomir transfection was performed using miRNA-21 and miRNA-221 antisense oligonucleotides (ASOs) and followed by detection of cell apoptosis, cell cycle progression, chemosensitivity, and invasion. Sorted SP cells from gemcitabine-resistant L3.6pl cells (L3.6plGres-SP) cells were orthotopically implanted in nude mice with or without miRNA-21 and miRNA-221 ASOs mono- and combination therapy. The administration of antagomir-21 and antagomir-221 significantly reduced the SP cell fraction, decreased SP cell differentiation, and downstream gene regulation, and thereby induced reduction of L3.6pl cell proliferation, invasion, and chemoresistance against gemcitabine and 5-Fluorouracil. Combination of ASOs therapy against miRNA-21 and miRNA-221 significantly inhibited primary tumor growth and metastasis compared to single antagomir treatment, especially, in L3.6plGres-SP-induced pancreatic tumor growth in vivo. These findings further indicate that the inhibition of miR-21 and miR-221 appear particularly suitable to target stem-like subpopulations and address their specific biological function to promote tumor progression in pancreatic cancer.
      datePublished:2015-02-03T00:00:00Z
      dateModified:2015-02-03T00:00:00Z
      pageStart:535
      pageEnd:548
      sameAs:https://doi.org/10.1007/s11523-015-0360-2
      keywords:
         miRNAs
         Side population
         Tumorigenesis
         Metastasis
         Chemotherapy resistance
         Pancreatic cancer
         Oncology
         Biomedicine
         general
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig3a_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig3b_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-015-0360-2/MediaObjects/11523_2015_360_Fig6_HTML.gif
      isPartOf:
         name:Targeted Oncology
         issn:
            1776-260X
            1776-2596
         volumeNumber:10
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yue Zhao
            affiliation:
                  name:Otto-von-Guericke University
                  address:
                     name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Lu Zhao
            affiliation:
                  name:University of Munich
                  address:
                     name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ivan Ischenko
            affiliation:
                  name:University of Munich
                  address:
                     name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qi Bao
            affiliation:
                  name:University of Munich
                  address:
                     name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bettina Schwarz
            affiliation:
                  name:University of Munich
                  address:
                     name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hanno NieรŸ
            affiliation:
                  name:University of Munich
                  address:
                     name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yan Wang
            affiliation:
                  name:Otto-von-Guericke University
                  address:
                     name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Andrea Renner
            affiliation:
                  name:University of Munich
                  address:
                     name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Josef Mysliwietz
            affiliation:
                  name:Institute of Molecular Immunology, Helmholtz Center Munich
                  address:
                     name:Institute of Molecular Immunology, Helmholtz Center Munich, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Karl-Walter Jauch
            affiliation:
                  name:University of Munich
                  address:
                     name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter J. Nelson
            affiliation:
                  name:University of Munich
                  address:
                     name:Clinical Biochemistry Group, Medizinische Klinik und Poliklinik IV, University of Munich, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joachim W. Ellwart
            affiliation:
                  name:Institute of Molecular Immunology, Helmholtz Center Munich
                  address:
                     name:Institute of Molecular Immunology, Helmholtz Center Munich, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christiane J. Bruns
            affiliation:
                  name:Otto-von-Guericke University
                  address:
                     name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter Camaj
            affiliation:
                  name:Otto-von-Guericke University
                  address:
                     name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Targeted Oncology
      issn:
         1776-260X
         1776-2596
      volumeNumber:10
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Otto-von-Guericke University
      address:
         name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
         type:PostalAddress
      name:University of Munich
      address:
         name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
         type:PostalAddress
      name:University of Munich
      address:
         name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
         type:PostalAddress
      name:University of Munich
      address:
         name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
         type:PostalAddress
      name:University of Munich
      address:
         name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
         type:PostalAddress
      name:University of Munich
      address:
         name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
         type:PostalAddress
      name:Otto-von-Guericke University
      address:
         name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
         type:PostalAddress
      name:University of Munich
      address:
         name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
         type:PostalAddress
      name:Institute of Molecular Immunology, Helmholtz Center Munich
      address:
         name:Institute of Molecular Immunology, Helmholtz Center Munich, Munich, Germany
         type:PostalAddress
      name:University of Munich
      address:
         name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
         type:PostalAddress
      name:University of Munich
      address:
         name:Clinical Biochemistry Group, Medizinische Klinik und Poliklinik IV, University of Munich, Munich, Germany
         type:PostalAddress
      name:Institute of Molecular Immunology, Helmholtz Center Munich
      address:
         name:Institute of Molecular Immunology, Helmholtz Center Munich, Munich, Germany
         type:PostalAddress
      name:Otto-von-Guericke University
      address:
         name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
         type:PostalAddress
      name:Otto-von-Guericke University
      address:
         name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yue Zhao
      affiliation:
            name:Otto-von-Guericke University
            address:
               name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Lu Zhao
      affiliation:
            name:University of Munich
            address:
               name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Ivan Ischenko
      affiliation:
            name:University of Munich
            address:
               name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Qi Bao
      affiliation:
            name:University of Munich
            address:
               name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Bettina Schwarz
      affiliation:
            name:University of Munich
            address:
               name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Hanno NieรŸ
      affiliation:
            name:University of Munich
            address:
               name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Yan Wang
      affiliation:
            name:Otto-von-Guericke University
            address:
               name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
               type:PostalAddress
            type:Organization
      name:Andrea Renner
      affiliation:
            name:University of Munich
            address:
               name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Josef Mysliwietz
      affiliation:
            name:Institute of Molecular Immunology, Helmholtz Center Munich
            address:
               name:Institute of Molecular Immunology, Helmholtz Center Munich, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Karl-Walter Jauch
      affiliation:
            name:University of Munich
            address:
               name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Peter J. Nelson
      affiliation:
            name:University of Munich
            address:
               name:Clinical Biochemistry Group, Medizinische Klinik und Poliklinik IV, University of Munich, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Joachim W. Ellwart
      affiliation:
            name:Institute of Molecular Immunology, Helmholtz Center Munich
            address:
               name:Institute of Molecular Immunology, Helmholtz Center Munich, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Christiane J. Bruns
      affiliation:
            name:Otto-von-Guericke University
            address:
               name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
               type:PostalAddress
            type:Organization
      name:Peter Camaj
      affiliation:
            name:Otto-von-Guericke University
            address:
               name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
      name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
      name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
      name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
      name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
      name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
      name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
      name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
      name:Institute of Molecular Immunology, Helmholtz Center Munich, Munich, Germany
      name:Department of General, Visceral und Vascular Surgery, University of Munich, Munich, Germany
      name:Clinical Biochemistry Group, Medizinische Klinik und Poliklinik IV, University of Munich, Munich, Germany
      name:Institute of Molecular Immunology, Helmholtz Center Munich, Munich, Germany
      name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
      name:Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {๐Ÿ”—}(208)

Analytics and Tracking {๐Ÿ“Š}

  • Google Tag Manager

Libraries {๐Ÿ“š}

  • Clipboard.js
  • Prism.js

CDN Services {๐Ÿ“ฆ}

  • Crossref

4.97s.